Nutrien Q2 2026 slides show EBITDA growth amid volume pressures

Nutrien reported first-half 2026 adjusted EBITDA of $3.535B (+6%) and net earnings of $1.361B (+9%), but Q2 results were mixed with EPS missing expectations. The company raised the bottom end of potash volume guidance to 14.2-14.8Mt and lowered 2026 capex to $1.95B-$2.05B (from $2.0B-$2.1B), while also accelerating buybacks to about $75M/month. Offsetting headwinds included retail volumes down 12% and nitrogen sales volumes down 25% to 2.25Mt on facility shutdowns/maintenance, keeping the overall tone cautious despite stronger pricing power in potash (+8% average net selling price to $267/t).

Analysis

The market is likely underpricing the quality of the EBITDA mix shift. Potash is becoming the cleanest earnings lever, and with capital returns accelerating, NTR is less a pure volume story than a per-share cash conversion story. The real relative loser is any fertilizer name that lacks both logistics flexibility and a self-help narrative; NTR can absorb a choppy crop-input tape better than a more concentrated peer set.

Near term, the key catalysts are fall application volumes and year-end portfolio decisions, not the quarter itself. If nitrogen outages are temporary, normalized production plus lower gas should lift margins into 1H27; if they persist, the stock loses operating leverage, but divestiture proceeds and buybacks still put a floor under equity value. The biggest swing factor remains potash pricing: small moves there can overwhelm the headline EPS noise over the next 1-3 months.

Contrarian view: consensus is overreacting to the earnings miss and underweighting balance-sheet repair plus buyback math. This is one of the few ag-input names where flat unit growth can still produce equity upside if the share count keeps falling. The thesis breaks if potash pricing rolls over, global shipment assumptions weaken, or the strategic review slips beyond year-end and turns into a protracted overhang.

Key Decisions for Investors

• Buy NTR on weakness in the $65-66 area for a 3-6 month trade; target a move back toward the low-70s if potash pricing stays firm and Q3 application demand confirms.
• Pair trade: long NTR / short MOS over the next 1-3 months to express stronger self-help, better capital return, and less reliance on a single commodity leg; stop the trade if phosphate pricing reaccelerates or NTR delays portfolio actions.
• If options liquidity is attractive, use a bullish call spread in NTR rather than outright stock to monetize the catalyst path into the November investor day; use as a defined-risk way to capture a rerating from buybacks and asset sales.
• Set an alert on potash spot prices and NTR guidance: if potash ASPs drop materially from current levels or management trims the 2026 volume range, exit the long immediately.